TLDR
- WORK Medical plunges after Nasdaq delisting notice, plans urgent appeal.
- Nasdaq moves to delist WORK Medical; firm eyes appeal and reverse split.
- WORK Medical faces delisting threat after stock stays under $0.10 mark.
- Nasdaq delisting looms for WORK Medical; shares crash over 24% overnight.
- WORK Medical fights Nasdaq delisting with last-minute compliance measures.
WORK Medical Technology Group Ltd (NASDAQ: WOK) saw a sharp drop in its stock value on October 14, 2025. Shares closed at $0.0745, marking a 4.12% daily loss, and extended losses overnight by 24.83% to $0.0560.
WORK Medical Technology Group Ltd (WOK)
This significant fall followed a delisting determination issued by the Nasdaq Stock Market.
Nasdaq sent a formal letter on October 9, 2025, notifying the company of its intent to remove the stock from the exchange. This decision came after the stock closed below $0.10 for ten consecutive trading sessions, ending October 8, 2025. The breach of Nasdaq Listing Rule 5810(c)(3)(A)(iii) prompted the delisting notice.
If the company does not appeal, trading will be suspended on October 20, 2025. Nasdaq will file a Form 25-NSE with the U.S. Securities and Exchange Commission to complete the delisting. This action will remove WORK Medical’s securities from both listing and registration.
Company Plans Appeal to Delay Suspension
WORK Medical intends to appeal the Nasdaq determination before the October 16, 2025 deadline. A formal hearing request will pause the trading suspension until the Nasdaq Hearings Panel makes a decision. This appeal process may offer temporary relief, but the outcome remains uncertain.
The company has also begun evaluating methods to restore compliance with Nasdaq’s listing requirements. One potential option under review includes a reverse share split to raise the stock price above the $0.10 threshold. Such corporate actions aim to prevent the company from being permanently delisted from the U.S. exchange.
This move reflects an urgent effort by the company to maintain its presence in U.S. capital markets. Remaining listed is critical for access to capital, visibility, and credibility. However, the window to regain compliance is narrowing quickly.
Chinese-Based Medical Device Supplier
WORK Medical Technology Group Ltd operates through its Chinese subsidiary Work (Hangzhou) Medical Treatment Equipment Co., Ltd. The company manufactures and sells Class I and II medical devices and disposable medical products. Its product line includes 21 items such as multifunctional masks and other medical consumables.
The company sells products across all 34 provincial-level regions in China and exports to more than 30 countries worldwide. WORK Medical has received numerous quality certifications and holds FDA registrations for 17 products. This allows the company to enter and compete in the U.S. medical device market.
The firm now faces pressure from weak stock performance and regulatory non-compliance. The coming days will be pivotal as it prepares its appeal to the Nasdaq. Strategic steps will determine whether the company can stay listed or shift to over-the-counter trading.
